Compare COMBAT DRUGS with UNJHA FORMUL - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

COMBAT DRUGS vs UNJHA FORMUL - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    COMBAT DRUGS UNJHA FORMUL COMBAT DRUGS/
UNJHA FORMUL
 
P/E (TTM) x 22.6 -129.0 - View Chart
P/BV x 5.1 2.3 216.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 COMBAT DRUGS   UNJHA FORMUL
EQUITY SHARE DATA
    COMBAT DRUGS
Mar-21
UNJHA FORMUL
Mar-20
COMBAT DRUGS/
UNJHA FORMUL
5-Yr Chart
Click to enlarge
High Rs4111 374.1%   
Low Rs186 312.2%   
Sales per share (Unadj.) Rs55.023.7 232.5%  
Earnings per share (Unadj.) Rs1.40.7 202.1%  
Cash flow per share (Unadj.) Rs2.20.9 254.7%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs13.64.1 334.5%  
Shares outstanding (eoy) m10.104.48 225.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.50.4 151.8%   
Avg P/E ratio x21.312.2 174.8%  
P/CF ratio (eoy) x13.49.7 138.7%  
Price / Book Value ratio x2.22.1 105.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m29838 795.3%   
No. of employees `000NANA-   
Total wages/salary Rs m4734 10,685.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m556106 524.1%  
Other income Rs m63 253.3%   
Total revenues Rs m562109 517.7%   
Gross profit Rs m352 1,405.6%  
Depreciation Rs m81 1,036.7%   
Interest Rs m121 1,008.6%   
Profit before tax Rs m213 695.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m70-   
Profit after tax Rs m143 455.5%  
Gross profit margin %6.32.3 267.8%  
Effective tax rate %34.50-   
Net profit margin %2.52.9 86.8%  
BALANCE SHEET DATA
Current assets Rs m22526 875.6%   
Current liabilities Rs m17319 910.9%   
Net working cap to sales %9.46.4 148.1%  
Current ratio x1.31.4 96.1%  
Inventory Days Days770 20,355,746.5%  
Debtors Days Days76640 1,933.3%  
Net fixed assets Rs m16111 1,413.2%   
Share capital Rs m10145 225.4%   
"Free" reserves Rs m36-27 -134.5%   
Net worth Rs m13718 754.1%   
Long term debt Rs m670-   
Total assets Rs m38737 1,040.7%  
Interest coverage x2.83.7 77.3%   
Debt to equity ratio x0.50-  
Sales to assets ratio x1.42.9 50.4%   
Return on assets %6.711.4 58.2%  
Return on equity %10.217.0 60.3%  
Return on capital %16.223.4 69.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m184 467.3%  
From Investments Rs m-3-1 304.9%  
From Financial Activity Rs m40NA-  
Net Cashflow Rs m553 1,905.5%  

Share Holding

Indian Promoters % 0.0 36.9 -  
Foreign collaborators % 45.9 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 54.1 63.1 85.7%  
Shareholders   12,796 4,111 311.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare COMBAT DRUGS With:   SANOFI INDIA  EVEREST ORGANICS  ALEMBIC PHARMA  ABBOTT INDIA  PROCTER & GAMBLE HEALTH  



Today's Market

Sensex Snaps 2-Day Losing Streak, Zooms 887 Points, Nifty Settles Above 17,150; Tata Steel, Axis Bank Top Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

COMBAT DRUGS SHARE PRICE


Dec 7, 2021 (Close)

TRACK COMBAT DRUGS

  • Track your investment in COMBAT DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMBAT DRUGS 8-QTR ANALYSIS

COMPARE COMBAT DRUGS WITH

MARKET STATS